|
Index of reports
> Cases with Dehydration (95)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 95 Next >>
Possible Paclitaxel side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 100.7 kg (221.5 pounds)
Reactions: Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Blinded NO Treatment Received
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Fluorouracil
Dosage: unk
Start date: 2012-07-29
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Start date: 2012-07-15
End date: 2012-07-20
Hydroxyurea
Dosage: unk
Administration route: Oral
Start date: 2012-07-29
Hydroxyurea
Dosage: 500 mg, bid
Administration route: Oral
Start date: 2012-07-15
End date: 2012-07-20
Hydroxyurea
Dosage: 500 mg, bid
Administration route: Oral
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Paclitaxel
Dosage: 228 mg qwk
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: unk
Start date: 2012-07-29
Paclitaxel
Dosage: 228 mg qwk
Indication: Squamous Cell Carcinoma
Start date: 2012-07-02
Placebo
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Other drugs received by patient: Fentanyl; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Senna; Bacitracin; Filgrastim; Morphine; Famotidine; Fluconazole; Eucerin; Prochlorperazine; Esomeprazole Sodium; Guaifenesin; Enoxaparin; Amoxicillin and Clavulanate Potassium; Miralax; Lidocaine; Escitalopram; Ondansetron; Rosuvastatin; Docusate; Aquaphor; Hydromorphone Hydrochloride; Nystatin
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-08-22
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Other drugs received by patient: Zamanon; Marinol; Metformin; Maxolon
Possible Paclitaxel side effects in 60 year old female
Reported by a physician from United States on 2012-08-10
Patient: 60 year old female, weighing 54.3 kg (119.4 pounds)
Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia
Drug(s) suspected as cause:
Herceptin
Start date: 2012-06-15
End date: 2012-06-15
Herceptin
Start date: 2012-07-09
Herceptin
Dosage: cyclic on day 1,8,15 and 24
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Neratinib
Dosage: c1d8
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Neratinib
Dosage: c1d1
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Paclitaxel
Dosage: cyclic on day 1,8 and 15 (c1d8)
Start date: 2012-06-15
End date: 2012-06-15
Paclitaxel
Dosage: c1d1
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Possible Paclitaxel side effects in male
Reported by a physician from United States on 2012-08-03
Patient: male, weighing 100.7 kg (221.5 pounds)
Reactions: Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Blinded NO Treatment Received
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Start date: 2012-07-15
End date: 2012-07-20
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Indication: Squamous Cell Carcinoma
Start date: 2012-07-15
End date: 2012-07-06
Hydroxyurea
Dosage: 500 mg, unk
Administration route: Oral
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Hydroxyurea
Dosage: 500 mg, unk
Administration route: Oral
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: 228 mg qwk
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: 228 mg qwk
Indication: Squamous Cell Carcinoma
Start date: 2012-07-02
Placebo
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Other drugs received by patient: Bacitracin; Fentanyl Citrate; Miralax; Escitalopram; Senna-Mint WAF; Famotidine; Filgrastim; Fluconazole; Eucerin; Aquaphor; Prochlorperazine; Ondansetron; Lidocaine; Morphine Sulfate; Amoxicillin and Clavulanate Potassium; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Rosuvastatin
Possible Paclitaxel side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-02
Patient: female, weighing 110.1 kg (242.2 pounds)
Reactions: Dyspnoea, Chest Pain, Tachycardia, Dehydration, Suicidal Ideation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 800 mg
Paclitaxel
Dosage: 380 mg
Possible Paclitaxel side effects in 56 year old female
Reported by a physician from United States on 2012-07-27
Patient: 56 year old female
Reactions: Abdominal Pain, Vomiting, Nausea, Dehydration, Wound Complication
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: cycle=21 days (cycle 1-6)
Indication: Ovarian Epithelial Cancer
Start date: 2011-06-13
Bevacizumab
Dosage: cycle=21 days (cycle 1-6)
Start date: 2012-03-12
Carboplatin
Dosage: cycle=21 days (cycle 1-6), auc= 6 on day 1
Indication: Ovarian Epithelial Cancer
Start date: 2011-06-13
Docetaxel
Dosage: cycle=21 days (cycle 1-6)
Indication: Ovarian Epithelial Cancer
Start date: 2011-06-13
Paclitaxel
Dosage: cycle=21 days (cycle 1-6), over 3 hours day 1
Indication: Ovarian Epithelial Cancer
Start date: 2011-06-13
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 54.2 kg (119.2 pounds)
Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia
Drug(s) suspected as cause:
Neratinib
Dosage: 200 mg, 1x/day (c1d8)
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Neratinib
Dosage: c1d1
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Paclitaxel
Dosage: c1d1
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Paclitaxel
Dosage: 120 mg, cyclic on day 1 ,8 and 15 (c1d8)
Start date: 2012-06-15
End date: 2012-06-15
Trastuzumab
Dosage: 4 mg/kg, (200/100 mg) cyclic on day 1, 8, 15 and 24 (c1d8)
Start date: 2012-06-15
End date: 2012-06-15
Trastuzumab
Dosage: c1d1
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-08
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-20
Patient: female, weighing 123.8 kg (272.4 pounds)
Reactions: Syncope, Urinary Tract Infection, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-01-05
Cisplatin
Dosage: 25 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-01-05
Paclitaxel
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-01-05
Possible Paclitaxel side effects in 63 year old female
Reported by a physician from United States on 2012-07-18
Patient: 63 year old female, weighing 122.7 kg (270.0 pounds)
Reactions: Vomiting, Nausea, Pain, Anaemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Skin Ulcer, Hypomagnesaemia, Dehydration, Hypoalbuminaemia, Hypocalcaemia, Vaginal Infection, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: over 30-90 minutes on day 1,starting with cycle 2 x6 cycles, no prior radiotherapy
Indication: Endometrial Cancer
Start date: 2011-05-02
Avastin
Dosage: prior radiotherapy, iv over 30-90 minutes on day 1 (
Carboplatin
Dosage: auc = 5 iv over 30 minutes on day 1 x 6 cycles
Carboplatin
Dosage: no prior radiotherapy, auc = 6 iv over 30 minutes on day 1 x 6 cycles
Indication: Endometrial Cancer
Start date: 2011-05-02
Paclitaxel
Dosage: prior radiotherapy,over 3 hrs on day 1 x 6 cycles
Paclitaxel
Dosage: no prior radiotherapy, iv over 3 hrs on day 1 x 6 cycles
Indication: Endometrial Cancer
Start date: 2011-05-02
Other drugs received by patient: Arixtra; Percocet; Lyrica
Possible Paclitaxel side effects in 55 year old female
Reported by a physician from Germany on 2012-07-16
Patient: 55 year old female
Reactions: Vomiting, Diarrhoea, Dehydration, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 50 mg/m2, unk
Indication: non-Small Cell Lung Cancer Stage Iiib
Start date: 2012-05-22
End date: 2012-05-22
Cisplatin
Dosage: 50 mg/m2, unk
Indication: non-Small Cell Lung Cancer Stage Iiia
Start date: 2012-05-15
End date: 2012-05-15
Paclitaxel
Dosage: 175 mg/m2, unk
Indication: non-Small Cell Lung Cancer Stage Iiia
Start date: 2012-05-15
End date: 2012-05-15
Paclitaxel
Indication: non-Small Cell Lung Cancer Stage Iiib
Possible Paclitaxel side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient: male, weighing 104.0 kg (228.8 pounds)
Reactions: Dehydration, Pyrexia, Blood Sodium Decreased, Decreased Appetite, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 900 mg
Cetuximab (Erbitux) 537 MG
Dosage: 537 mg
Paclitaxel
Dosage: 462 mg
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-07-05
Patient: female, weighing 54.2 kg (119.2 pounds)
Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia
Drug(s) suspected as cause:
Neratinib
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-20
Paclitaxel
Dosage: 120 mg, day 1,8,15
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-15
Trastuzumab
Dosage: 200/100 mg daily 1/8,15,24
Indication: Breast Cancer Metastatic
Start date: 2012-06-08
End date: 2012-06-15
Possible Paclitaxel side effects in male
Reported by a physician from United States on 2012-07-04
Patient: male, weighing 71.7 kg (157.7 pounds)
Reactions: Cardio-Respiratory Arrest, Pneumonia, Dehydration, Atrial Fibrillation
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Indication: Squamous Cell Carcinoma
Blinded NO Treatment Received
Dosage: unk
Indication: Squamous Cell Carcinoma
Cisplatin
Dosage: 140.25 mg, q21d
Indication: Squamous Cell Carcinoma
Start date: 2010-11-30
Comparator Cetuximab
Dosage: 467.5 mg, unk
Indication: Squamous Cell Carcinoma
Start date: 2010-12-07
Paclitaxel
Dosage: 327.3 mg, q21d
Indication: Squamous Cell Carcinoma
Start date: 2010-11-30
Placebo
Dosage: unk
Indication: Squamous Cell Carcinoma
Rad001
Dosage: 5 mg, qd
Administration route: Oral
Indication: Squamous Cell Carcinoma
Start date: 2010-12-07
Other drugs received by patient: Nicotine; Xalatan; Symbicort; Tiotropium Bromide; Enzymes; Albuterol; Proventil; Enoxaparin; Dexamethasone Sodium Phosphate; Trusopt
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-06-27
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Diabetic Ulcer, Hyperglycaemia, Neoplasm Progression, Hyponatraemia, Hypokalaemia, Renal Impairment, Fatigue, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Other drugs received by patient: Maxolon; Marinol; Zamanon; Metformin HCL
Possible Paclitaxel side effects in 55 year old female
Reported by a physician from Germany on 2012-06-22
Patient: 55 year old female
Reactions: Vomiting, Diarrhoea, Dehydration, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer Stage Iiib
Cisplatin
Dosage: 50 mg/m2,unk
Indication: non-Small Cell Lung Cancer Stage Iiia
Start date: 2012-05-15
Paclitaxel
Indication: non-Small Cell Lung Cancer Stage Iiib
Paclitaxel
Dosage: 175 mg/m2,unk
Indication: non-Small Cell Lung Cancer Stage Iiia
Start date: 2012-05-15
Vinorelbine
Dosage: unk
Indication: non-Small Cell Lung Cancer Stage Iiia
Vinorelbine
Indication: non-Small Cell Lung Cancer Stage Iiib
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-06-19
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Fatigue, Neoplasm Malignant, Dehydration, Sepsis, Skin Lesion, Cardiac Arrest, Pneumonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Other drugs received by patient: Maxolon; Marinol; Zamanon; Metformin HCL
Possible Paclitaxel side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13
Patient: 56 year old female, weighing 85.7 kg (188.5 pounds)
Reactions: Electrocardiogram ST-T Change, Blood Potassium Decreased, Dehydration, Hypotension, Cardiac Enzymes Increased, Breast Cancer Female, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine
Dosage: (10 mg, 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2008-03-03
Cyclophosphamide
Dosage: 600 mg/m2, day 1 of c 5-8, intravenous
Indication: Breast Cancer
Start date: 2012-03-27
End date: 2012-05-29
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, day 1 of c# 5-8, intravenous
Indication: Breast Cancer
Start date: 2012-03-27
End date: 2012-05-29
Hydrochlorothiazide
Dosage: (125 mg, 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-10-21
Lisinopril
Dosage: (20 mg, 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2008-10-21
Neratinib
Dosage: (240 mg, 1 d), oral
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-12-12
End date: 2012-03-26
Paclitaxel
Dosage: 80 mg/m2, cyclic, day 1, 8, 15 of c#1-4; intravenous
Indication: Breast Cancer
Start date: 2011-12-12
End date: 2012-03-13
Other drugs received by patient: Zantac
Possible Paclitaxel side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: 60 year old female, weighing 79.8 kg (175.6 pounds)
Reactions: Metastases To Chest Wall, Vomiting, Cellulitis, Pain in Extremity, Nausea, Metastases To Lymph Nodes, Culture Stool Positive, Fatigue, Diarrhoea, Dehydration, Lymphoedema, Candidiasis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paclitaxel
Dosage: 80 mg/m2 over 1 hr, 1 in 28 days, iv drip
Indication: Breast Cancer
Start date: 2005-05-04
Tarceva
Dosage: 100 mg, uid/qd, oral
Administration route: Oral
Indication: Breast Cancer
Start date: 2005-05-04
Trastuzumab (Trastuzumab) Injection
Dosage: 2 mg/kg over 30 min, 1 in 28 days, iv nos
Indication: Breast Cancer
Start date: 2005-05-04
Possible Paclitaxel side effects in 60 year old female
Reported by a individual with unspecified qualification from United States on 2012-06-01
Patient: 60 year old female, weighing 79.7 kg (175.3 pounds)
Reactions: Fatigue, Diarrhoea, Dehydration, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Tarceva
Administration route: Oral
Indication: Breast Cancer
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-05-29
Patient: female, weighing 72.7 kg (159.9 pounds)
Reactions: White Blood Cell Count Decreased, Vomiting, Nausea, Anaemia, Toxicity To Various Agents, Fall, Syncope, Dehydration, Presyncope, Dizziness, Blood Creatinine Increased, Thrombocytopenia, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 395 mg
End date: 2012-03-27
Paclitaxel
Dosage: 160 mg
End date: 2012-04-10
Possible Paclitaxel side effects in
Reported by a individual with unspecified qualification from United States on 2012-05-28
Patient:
Reactions: Pain, Mental Status Changes, Pulmonary Embolism, Constipation, Neuropathy Peripheral, Fatigue, Dyspepsia, Oral Candidiasis, Oedema, Decreased Appetite, Hypovolaemia, Blood Alkaline Phosphatase Increased, Vomiting, Dysphagia, Nausea, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Brachial Plexopathy, Anxiety, Mucosal Inflammation, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Neutropenia
Drug(s) suspected as cause:
Paclitaxel
Dosage: on days 1-8
Indication: Breast Cancer Metastatic
Xeloda
Dosage: on days 1-15
Administration route: Oral
Indication: Breast Cancer Metastatic
Possible Paclitaxel side effects in male
Reported by a physician from United States on 2012-05-22
Patient: male, weighing 73.0 kg (160.6 pounds)
Reactions: Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Axitinib
Dosage: 3 mg, 2x/day
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2012-01-31
Carboplatin
Dosage: 430 mg, auc4
Indication: Metastatic Malignant Melanoma
Start date: 2012-01-31
Paclitaxel
Dosage: 125 mg/m2, cyclic, every 3 weeks
Indication: Metastatic Malignant Melanoma
Start date: 2012-01-31
Other drugs received by patient: Atenolol; Lisinopril; Maxidex; Ativan; Tylenol; Zetar; Acidophilus; Nystatin; Tricor; Pradaxa; Vitamin D
Possible Paclitaxel side effects in 55 year old male
Reported by a consumer/non-health professional from Ireland on 2012-05-18
Patient: 55 year old male
Reactions: Blood Bilirubin Increased, Anion GAP Increased, Blood Calcium Increased, Thyroxine Free Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Blood Sodium Decreased, Renal Failure Acute, Decreased Appetite, Blood Chloride Decreased, Hyperglycaemia, Blood Thyroid Stimulating Hormone Decreased, Globulins Increased, Autoimmune Disorder, Haemoglobin Decreased, Diarrhoea, Dehydration, Colitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded: Ipilimumab
Dosage: last dose received on 26-apr-2012
Indication: non-Small Cell Lung Cancer
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-24
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-24
Placebo
Indication: non-Small Cell Lung Cancer
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-05-17
Patient: female
Reactions: Diarrhoea, Dehydration, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Docusate Sodium
Indication: Product Used FOR Unknown Indication
Erlotinib Hydrochloride
Dosage: cycle every 28 days
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-10-19
Herceptin
Indication: Product Used FOR Unknown Indication
Start date: 2006-10-17
Magnesium NOS
Indication: Product Used FOR Unknown Indication
Metoclopramide Hydrochloride
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Product Used FOR Unknown Indication
Start date: 2006-10-17
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-05-14
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Fatigue, Renal Impairment, Neoplasm Malignant, Sepsis, Skin Lesion, Dehydration, Cardiac Arrest, Pneumonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Other drugs received by patient: Metformin HCL; Marinol; Zamanon; Maxolon
Possible Paclitaxel side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-05-13
Patient: 55 year old male
Reactions: Diarrhoea, Dehydration, Colitis, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded: Ipilimumab
Dosage: last dose received on 26-apr-2012
Indication: non-Small Cell Lung Cancer
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-24
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2012-02-24
Placebo
Indication: non-Small Cell Lung Cancer
Possible Paclitaxel side effects in 73 year old
Reported by a physician from United States on 2012-04-30
Patient: 73 year old
Reactions: Hyperkalaemia, Diarrhoea, Dehydration, Haematuria, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer Metastatic
Start date: 2008-12-31
Carboplatin
Indication: Breast Cancer Metastatic
Start date: 2008-10-31
Herceptin
Dosage: maintainance dose
Start date: 2008-10-31
Herceptin
Dosage: loading dose
Indication: Breast Cancer Metastatic
Start date: 2008-10-31
Paclitaxel
Indication: Breast Cancer Metastatic
Start date: 2008-10-31
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-04-27
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Vomiting, Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Fatigue, Renal Impairment, Neoplasm Malignant, Dehydration, Sepsis, Skin Lesion, Cardiac Arrest, Pneumonitis, Decreased Appetite
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
End date: 2010-10-04
Other drugs received by patient: Marinol; Maxolon; Zamanon; Metformin HCL
Possible Paclitaxel side effects in 55 year old female
Reported by a individual with unspecified qualification from United States on 2012-04-27
Patient: 55 year old female
Reactions: Myalgia, Syncope, Diarrhoea, Nausea, Exfoliative Rash, Dehydration, Depression, Hypokalaemia
Drug(s) suspected as cause:
Anastrozole
Dosage: interrupted
Indication: Product Used FOR Unknown Indication
Docetaxel
Indication: Breast Cancer
Start date: 2010-04-09
Herceptin
Dosage: variable dose
Indication: Breast Cancer
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-04-09
Lapatinib
Administration route: Oral
Paclitaxel
Indication: Breast Cancer
Start date: 2010-04-09
Other drugs received by patient: Cream NOS; Lisinopril
Possible Paclitaxel side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26
Patient: 62 year old male, weighing 78.0 kg (171.6 pounds)
Reactions: Death, Vomiting, Nausea, Haemoptysis, Dehydration, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: non-Small Cell Lung Cancer
Start date: 2009-10-07
End date: 2009-10-07
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2009-10-07
End date: 2009-10-07
Paclitaxel
Indication: non-Small Cell Lung Cancer
Start date: 2009-10-07
End date: 2009-10-07
Other drugs received by patient: Avalide; Flomax; Lipitor; Guaifenesin + Codeine; Lortab; Phenergan HCL; Zofran
Page 1 Next >>
|
